Evaluating the efficiency of surgical treatment of ACTH-dependent Cushing’s syndrome in the early and late postoperative period
Main Article Content
Background. Adrenocorticotropic hormone-dependent Cushing’s syndrome (ACTH-dependent CS) is a form of endogenous CS caused by abnormal production of ACTH, in 80 % of cases — due to ACTH oversecretion by a pituitary adenoma (Cushing’s disease), and in 20 % of cases — as a result of ectopic ACTH secretion by an extrapituitary tumor or, very rarely, due to a tumor secreting both ACTH and corticotropin-releasing hormone. The purpose of our study was to evaluate the efficiency of the treatment for ACTH-dependent CS in the postoperative period. Materials and methods. Under supervision, there were 234 patients, out of them 160 women and 74 men aged 26.38 ± 3.40 years. The set of researches included clinical, biochemical, hormonal studies and also magnetic resonance imaging. Results. Transnasal transsphenoidal adenomectomies were performed initially for 200 patients, out of them for the second time — in 34 persons. The significance of differences was certain between such parameters, as a number of patients in the period of remission and number of relapses after transnasal transsphenoidal adenomectomy, level of free plasma cortisol and glycemia in the period of remission. After analyzing the data on the remissions and relapses, the correlation between free plasma cortisol level in the early postoperative period after transnasal transsphenoidal adenomectomy and the incidence of relapses was selectively studied in patients. Conclusions. The most significant, informing prognostic marker of tumor relapse is the level of plasma cortisol in the early postoperative period.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Castinetti F, Martinie M, Morange I, et al. A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease. J Clin Endocrinol Metab. 2009 Jun;94(6):1897-903. doi: 10.1210/jc.2008-2234.
Czepielewski MA, Rollin GA, Casagrande A, Ferreira NP. Criteria of cure and remission in Cushing's disease: an update. Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1362-72. PMID: 18209875.
Fleseriu M. Medical management of persistent and recurrent Cushing disease. Neurosurg Clin N Am. 2012 Oct;23(4):653-68. doi: 10.1016/j.nec.2012.06.012.
Hassan-Smith ZK, Sherlock M, Reulen RC, et al. Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years. J Clin Endocrinol Metab. 2012 Apr;97(4):1194-201. doi: 10.1210/jc.2011-2957.
Findling JW, Raff H. Diagnosis of endocrine disease: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome). Eur J Endocrinol. 2017 May;176(5):R205-R216. doi: 10.1530/EJE-16-0946.
Kuan EC, Yoo F, Kim W. et al. Anatomic Variations in Pituitary Endocrinopathies: Implications for the Surgical Corridor. J Neurol Surg B Skull Base. 2017 Apr;78(2):105-11. doi: 10.1055/s-0036-1585588.
Koutourousiou M, Winstead WI. Endoscopic Endonasal Surgery for Remission of Cushing Disease Caused by Ectopic Intracavernous Macroadenoma: Case Report and Literature Review. World Neurosurg. 2017 Feb;98:870.e5-870.e10. doi: 10.1016/j.wneu.2016.12.021.
Lambert JK, Goldberg L, Fayngold S, Kostadinov J, Post KD, Geer EB. Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients. J Clin Endocrinol Metab. 2013 Mar;98(3):1022-30. doi: 10.1210/jc.2012-2893.
Lonser RR, Wind JJ, Nieman LK, Weil RJ, DeVroom HL, Oldfield EH. Outcome of surgical treatment of 200 children with Cushing's disease. J Clin Endocrinol Metab. 2013 Mar;98(3):892-901. doi: 10.1210/jc.2012-3604.
Lindsay JR, Oldfield EH, Stratakis CA, Nieman LK. The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery. J Clin Endocrinol Metab. 2011 Jul;96(7):2057-64. doi: 10.1210/jc.2011-0456.
Melo-Leite AF, Elias PC, Teixeira SR, et al. Adrenocortical neoplasms in adulthood and childhood: distinct presentation. Review of the clinical, pathological and imaging characteristics. J Pediatr Endocrinol Metab. 2017 Mar 1;30(3):253-76. doi: 10.1515/jpem-2016-0080.
Prete A, Corsello SM, Salvatori R. Current best practice in the management of patients after pituitary surgery. Ther Adv Endocrinol Metab. 2017 Mar;8(3):33-48. doi: 10.1177/2042018816687240.
Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER Jr. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease. Neurosurgery. 2008 Aug;63(2):266-70; discussion 270-1. doi: 10.1227/01.NEU.0000313117.35824.9F.
Romanholi DJ, Machado MC, Pereira CC, et al. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease. Clin Endocrinol (Oxf). 2008 Jul;69(1):117-22. doi: 10.1111/j.1365-2265.2007.03168.x.
Santos A, Crespo I, Aulinas A, Resmini E, Valassi E, Webb SM. Quality of life in Cushing's syndrome. Pituitary. 2015 Apr;18(2):195-200. doi: 10.1007/s11102-015-0640-y.
Valassi E, Biller BM, Swearingen B, et al. Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J Clin Endocrinol Metab. 2010 Feb;95(2):601-10. doi: 10.1210/jc.2009-1672.